Meta-Analysis of Risk Factors for Recurrence in Cervical Cancer Patients Following Fertility-Sparing Treatment

Clicks: 2
ID: 310129
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #468 of 490 articles by views in Frontiers in surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 490 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Background To identify and evaluate the main risk factors for recurrence in cervical cancer patients who undergo fertility- sparing treatment. Methods A comprehensive search of multiple databases, including PubMed, Embase, and Web of Science, was performed to identify studies assessing the recurrence risk in cervical cancer patients treated with fertility-sparing procedures. Data from eligible studies were pooled, and the relative risks (RR) with 95% confidence intervals (CI) were calculated to evaluate the association between various risk factors and recurrence risk.Results Ten studies met inclusion criteria. Recurrence risk was significantly higher in patients aged ≤30 years (RR 2.03, 95% CI 1.89–2.19), those with tumor size ≥2 cm (RR 1.94, 95% CI 1.82–2.06), stage >IA within the fertility-sparing spectrum (RR 2.46, 95% CI 2.29–2.64), lymphovascular space invasion (LVSI) positivity (RR 2.09, 95% CI 1.90–2.30), and lymph-node metastasis (RR 3.10, 95% CI 2.76–3.48). Heterogeneity was low across comparisons (I²≈0%), and no significant small-study effects were detected.Conclusion Age ≤30 years, tumor size ≥2 cm, stage >IA, LVSI positivity, and lymph-node metastasis are robust predictors of recurrence following fertility-sparing treatment in cervical cancer. Incorporating these variables into preoperative counseling, operative strategy, and follow-up planning may enhance oncologic safety while preserving reproductive potential in appropriately selected patients. Our findings are consistent with current guideline recommendations, which generally limit fertility-sparing approaches to tumors ≤2 cm, while tumors exceeding this threshold require cautious consideration and are usually not regarded as appropriate candidates outside of clinical trials or exceptional multidisciplinary contexts.
Reference Key
imported_1768922178_696f9c42aa4ba Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ma, Yaru
Journal Frontiers in surgery
Year Year not found
DOI
10.3389/fsurg.2025.1625067
URL
https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1625067/full
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.